Department Halts Sales of Substandard Diabetes Medication
Summary
The Department of Drug Management has halted the sale and distribution of the diabetes medicine Zilipid-One after laboratory testing found it substandard. The batch, produced by Time Pharmaceuticals in Nawalparasi, has been ordered recalled from the market immediately.
Key Points
- The Department of Drug Management has ordered an immediate halt to the sale and distribution of Zilipid-One, a diabetes medicine found to be substandard.
- The decision was made under Section 14 of the Drug Act, 2035, after testing at the National Drug Laboratory found its solubility below the required standard.
- Batch GM-070 of the 1mg medicine, produced by Time Pharmaceuticals in Nawalparasi, has been recalled from the market.
- Doctors, health workers, traders, and the public have been told not to prescribe, sell, distribute, or use the affected batch.
